Table 1.
Screen number | Age(years)/Gender | BDP (µg ) | LABA (L), Nasal steroid (N), LAMA(T), Antihistamine (A) | FEV1 (%) | Residual volume (%) | Resistance at 5 Hz (R5%) | Mannitol PD10 |
---|---|---|---|---|---|---|---|
1 | 50/M | 1600 | L | 77 | 159 | 202 | 95.53 |
2 | 52/F | 2000 | L | 66 | 456 | 115 | 30.39 |
6 | 52/M | 1000 | LNA | 67 | 83 | 109 | 139.73 |
3 | 63/M | 1600 | LN | 54 | 142 | 215 | 170.37 |
10 | 37 M | 2000 | LA | 71 | 170 | 129 | 13.28 |
23 | 65F | 1000 | L | 49 | 216 | 192 | 337.32 |
27 | 48 M | 2000 | L | 67 | 130 | 130 | 192.50 |
31 | 40/M | 2000 | LA | 44 | 224 | 213 | NR |
32 | 28/M | 1000 | L | 64 | 140 | 214 | 96.94 |
36 | 43 M | 2000 | L | 70 | 162 | 286 | 455.89 |
37 | 65/M | 1600 | – | 69 | 147 | 151 | 129.27 |
38 | 60/M | 2000 | – | 57 | 128 | 153 | 443.57 |
39 | 61/F | 2000 | N | 48 | 185 | 142 | NR |
40 | 52/M | 2000 | L | 63 | 153 | 200 | 121.69 |
41 | 52/M | 2000 | LN | 38 | 188 | 306 | NR |
Mean (SD) | 51 (10) | 1635 (448) | 58 (13) | 193 (100) | 184 (56) | 177 (2.81) |
Challenge not performed as FEV1 < 50% predicted. BDP, beclomethasone diproprionate equivalent; LABA, long acting beta-agonist; LAMA, long acting anti-muscarinic.